Value investing is easily one of the most popular ways to find great stocks in any market environment. After all, who wouldn’t want to find stocks that are either flying under the radar and are compelling buys, or offer up tantalizing discounts when compared to fair value?

One way to find these companies is by looking at several key metrics and financial ratios, many of which are crucial in the value stock selection process. Let’s put Envision Healthcare Corporation stock into this equation and find out if it is a good choice for value-oriented investors right now, or if investors subscribing to this methodology should look elsewhere for top picks:

PE Ratio

A key metric that value investors always look at is the Price to Earnings Ratio, or PE for short. This shows us how much investors are willing to pay for each dollar of earnings in a given stock, and is easily one of the most popular financial ratios in the world. The best use of the PE ratio is to compare the stock’s current PE ratio with: a) where this ratio has been in the past; b) how it compares to the average for the industry/sector; and c) how it compares to the market as a whole.

On this front, Envision Healthcare has a trailing twelve months PE ratio of 12.1, as you can see in the chart below:



This level actually compares pretty favorably with the market at large, as the PE for the S&P 500 stands at about 20.3. If we focus on the long-term PE trend, Envision Healthcare’s current PE level puts it below its midpoint of 19.8 over the past five years. In fact, the current level stands close to the lows for the stock, thus indicating immense scope for entry.



Further, the stock’s PE compares favorably with the Zacks Medical sector’s trailing twelve months PE ratio, which stands at 20.4. At the very least, this indicates that the stock is relatively undervalued right now, compared to its peers.
 


We should point out that Envision Healthcare has a forward PE ratio (price relative to this year’s earnings) of just 13.2 so it is fair to expect an increase in the company’s share price in the near future.

P/S Ratio

Another key metric to note is the Price/Sales ratio. This approach compares a given stock’s price to its total sales, where a lower reading is generally considered better. Some people like this metric more than other value-focused ones because it looks at sales, something that is far harder to manipulate with accounting tricks than earnings.

Right now, Envision Healthcare has a P/S ratio of about 0.9. This is much lower than the S&P 500 average, which comes in at 3.2 right now. Also, as we can see in the chart below, this is well below the highs for this stock in particular over the past few years.



If anything, EVHC is in the lower end of its range in the time period from a P/S metric, suggesting some level of undervalued trading—at least compared to historical norms.

Broad Value Outlook

In aggregate, Envision Healthcare currently has a Value Score of A, putting it into the top 20% of all stocks we cover from this look. This makes Envision Healthcare a solid choice for value investors, and some of its other key metrics make this pretty clear too.

For example, the PEG ratio for Envision Healthcare is just 0.9, a level that is lower than the industry average of 1.9. The PEG ratio is a modified PE ratio that takes into account the stock’s earnings growth rate. Clearly, EVHC is a solid choice on the value front from multiple angles.

What About the Stock Overall?

Though Envision Healthcare might be a good choice for value investors, there are plenty of other factors to consider before investing in this name. In particular, it is worth noting that the company has a Growth Score of C and a Momentum Score of A. This gives EVHC a Zacks VGM score — or its overarching fundamental grade — of A. (You can read more about the Zacks Style Scores here >>)

Meanwhile, the company’s recent earnings estimates have been quite discouraging. The current quarter has seen six estimates go lower in the past sixty days compared to no upward revisions, while the full year estimate has seen one upward revision and six downward revisions in the same time period.

This has had a negative impact on the consensus estimate, as the current quarter consensus estimate has risen by 6.3% in the past two months, while the full year estimate has inched lower by 2.3%. You can see the consensus estimate trend and recent price action for the stock in the chart below:

In light of these bearish trends, the stock has just a Zacks Rank #3 (Hold) which indicates why we are looking for in-line performance from the company in the near term.

Bottom Line

Envision Healthcare is an inspired choice for value investors, as it is hard to beat its incredible lineup of statistics on this front. Further, this Zacks Rank #3 company enjoys a solid Zacks Industry Rank (among Top 18% of more than 250 industries). However, the industry has underperformed the broader market over the past two years. This is visible from the chart below:



So, value investors might want to wait for estimates and analyst sentiment to turn around in this name first, but once that happens, this stock could be a compelling pick.

Can Hackers Put Money INTO Your Portfolio?

Earlier this month, credit bureau Equifax announced a massive data breach affecting 2 out of every 3 Americans. The cybersecurity industry is expanding quickly in response to this and similar events. But some stocks are better investments than others.

Zacks has just released Cybersecurity! An Investor’s Guide to help Zacks.com readers make the most of the $170 billion per year investment opportunity created by hackers and other threats. It reveals 4 stocks worth looking into right away.

Download the new report now>>